Advertisement

International Journal of Clinical Pharmacy

, Volume 37, Issue 6, pp 1235–1241 | Cite as

Tablet splitting of narrow therapeutic index drugs: a nationwide survey in Taiwan

  • Chia-Lin Chou
  • Chia-Chen Hsu
  • Chia-Yu Chou
  • Tzeng-Ji Chen
  • Li-Fang Chou
  • Yueh-Ching ChouEmail author
Research Article
First Online:

Abstract

Background Tablet splitting or pill splitting frequently occurs in daily medical practice. For drugs with special pharmacokinetic characters, such as drugs with narrow therapeutic index (NTI), unequal split tablets might lead to erroneous dose titration and it even cause toxicity. Objective The aim of this study was to investigate the frequency of prescribing split NTI drugs at ambulatory setting in Taiwan. Setting A population-based retrospective study was conducted using the National Health Insurance Research Database in Taiwan. All ambulatory visits were analyzed from the longitudinal cohort datasets of the National Health Insurance Research Database. Methods The details of ambulatory prescriptions containing NTI drugs were extracted by using the claims datasets of one million beneficiaries from National Healthcare Insurance Research Database in 2010 in Taiwan. The analyses were stratified by dosage form, patient age and the number of prescribed tablets in a single dose for each NTI drugs. Main outcome measures Number and distinct dosage forms of available NTI drug items in Taiwan, number of prescriptions involved split NTI drugs, and number of patients received split NTI drugs. Results A total of 148,548 patients had received 512,398 prescriptions of NTI drugs and 41.8 % (n = 62,121) of patients had received 36.3 % (n = 185,936) of NTI drug prescriptions in form of split tablets. The percentage of splitting was highest in digoxin prescriptions (81.0 %), followed by warfarin (72.0 %). In the elderly patients, split tablets were very prevalent with digoxin (82.4 %) and warfarin (84.5 %). Conclusion NTI drugs were frequently prescribed to be taken in split forms in Taiwan. Interventions may be needed to provide effective and convenient NTI drug use. Further studies are needed to evaluate the clinical outcome of inappropriate split NTI drugs.

Keywords

Narrow therapeutic index drugs Prescribing patterns Splitting frequency Tablet splitting Taiwan 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

This study is based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health and managed by National Health Research Institutes, Taiwan. The interpretation and conclusions contained herein do not represent those of Bureau of National Health Insurance, Department of Health or National Health Research Institutes.

Funding

This study was supported by Grants from Taipei Veterans General Hospital (V102C-160) and National Science Council in Taiwan (NSC 99-2410-H-004-029-MY3).

Conflicts of interest

The authors declare that they have no conflicts of interest.

References

  1. 1.
    Chou CY, Hsu CC, Chiang SC, Ho CC, Chou CL, Wu MS, et al. Association between physician specialty and risk of prescribing inappropriate pill splitting. PLoS One. 2013;8(7):e70113. doi: 10.1371/journal.pone.0070113 (eCollection 2013).PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Quinzler R, Gasse C, Schneider A, Kaufmann-Kolle P, Szecsenyi J, Haefeli WE. The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol. 2006;62(12):1065–73.CrossRefPubMedGoogle Scholar
  3. 3.
    Quinzler R, Schmitt SP, Pritsch M, Kaltschmidt J, Haefeli WE. Substantial reduction of inappropriate tablet splitting with computerised decision support: a prospective intervention study assessing potential benefit and harm. BMC Med Inform Decis Mak. 2009;9:30. doi: 10.1186/1472-6947-9-30 (eCollection 2009).PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Olliaro PL, Vaillant M, Hayes DJ, Montresor A, Chitsulo L. Practical dosing of praziquantel for schistosomiasis in preschool-aged children. Trop Med Int Health. 2013;18(9):1085–9.CrossRefPubMedGoogle Scholar
  5. 5.
    van Santen E, Barends DM, Frijlink HW. Breaking of scored tablets: a review. Eur J Pharm Biopharm. 2002;53(2):139–45.CrossRefPubMedGoogle Scholar
  6. 6.
    Choe HM, Stevenson JG, Streetman DS, Heisler M, Sandiford CJ, Piette JD. Impact of patient financial incentives on participation and outcomes in a statin pill-splitting program. Am J Manag Care. 2007;13(6):298–304.PubMedGoogle Scholar
  7. 7.
    Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, et al. Controlling prescription drug expenditures: a report of success. Am J Manag Care. 2007;13(8):473–80.PubMedGoogle Scholar
  8. 8.
    Peek BT, Al-Achi A, Coombs SJ. Accuracy of tablet splitting by elderly patients. JAMA. 2002;288(4):451–2.CrossRefPubMedGoogle Scholar
  9. 9.
    McDevitt JT, Gurst AH, Chen Y. Accuracy of tablet splitting. Pharmacotherapy. 1998;18(1):193–7.PubMedGoogle Scholar
  10. 10.
    Jiang W, Yu LX. Bioequivalence for narrow therapeutic index drugs. In: Yu L, Li B, editors. FDA bioequivalence standards. New York: Springer; 2014. p. 191–216.Google Scholar
  11. 11.
    Neidecker M, Patel AA, Nelson WW, Reardon G. Use of warfarin in long-term care: a systematic review. BMC Geriatr. 2012;12:14. doi: 10.1186/1471-2318-12-14 (eCollection 2012).PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Clark NP, Witt DM, Delate T, Trapp M, Garcia D, Ageno W, et al. Warfarin-associated research projects and other endeavors consortium. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study. Pharmacotherapy. 2008;28(8):960–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Blix HS, Viktil KK, Moger TA, Reikvam A. Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients. Pharm Pract (Internet). 2009;8(1):50–55. PMCID: PMC4140577.Google Scholar
  14. 14.
    Liang BA, Mackey TK, Lovett KM. Illegal “no prescription” internet access to narrow therapeutic index drugs. Clin Ther. 2013;35(5):694–700.CrossRefPubMedGoogle Scholar
  15. 15.
    Paveliu MS, Bengea S, Paveliu FS. Generic substitution issues: brand-generic substitution, generic-generic substitution, and generic substitution of narrow therapeutic index (nti)/critical dose drugs. Maedica. 2011;6(1):52–8.PubMedCentralPubMedGoogle Scholar
  16. 16.
    Helmy SA. Tablet splitting: is it worthwhile? Analysis of drug content and weight uniformity for half tablets of 16 commonly used medications in the outpatient setting. J Manag Care Spec Pharm. 2015;21(1):76–86.PubMedGoogle Scholar
  17. 17.
    Shah RB, Collier JS, Sayeed VA, Bryant A, Habib MJ, Khan MA. Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium. AAPS Pharm Sci Tech. 2010;11(3):1359–67.CrossRefGoogle Scholar
  18. 18.
    Bureau of National Health Insurance, Department of Health, Executive Yuan, “The National Health Insurance Statistics,” 2010. http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=296&WD_ID=296&webdata_id=4010. Accessed Aug 3 2015.
  19. 19.
    Chen YC, Yeh HY, Wu JC, Haschler I, Chen TJ, Wetter T. Taiwan’s national health insurance research database: administrative health care database as study object in bibliometrics. Scientometrics. 2010;86(2):365–80.CrossRefGoogle Scholar
  20. 20.
    Narrow therapeutic index drugs designated by the north carolina secretary of human resources. North Carolina Register. 2013;27(13):1263.Google Scholar
  21. 21.
    Fischbach MS, Gold JL, Lee M, Dergal JM, Litner GM, Rochon PA. Pill-splitting in a long-term care facility. CMAJ. 2001;164(6):785–6.PubMedCentralPubMedGoogle Scholar
  22. 22.
    Berg C, Ekedahl A. Dosages involving splitting tablets: common but unnecessary? J Pharm Health Serv Res. 2010;1(3):137–41.CrossRefGoogle Scholar
  23. 23.
    Vivo RP, Krim SR, Perez J, Inklab M, Tenner T Jr, Hodgson J. Digoxin: current use and approach to toxicity. Am J Med Sci. 2008;336:423–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Ehle M, Patel C, Giugliano RP. Digoxin: clinical highlights: a review of digoxin and its use in contemporary medicine. Crit Pathw Cardiol. 2011;10(2):93–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Information Product. Lanoxin, digoxin 2006. Greenville: GlaxoSmith-Kline; 2006.Google Scholar
  26. 26.
    Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc. 2003;78(12):1564–77.CrossRefPubMedGoogle Scholar
  27. 27.
    Currie GM, Wheat JM, Kiat H. Pharmacokinetic considerations for digoxin in older people. Open Cardiovasc Med J. 2011;5:130–5.PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Leendertse AJ, Van den Bemt PMLA, Poolman JB, Stoker LJ, Egberts ACG, Postma MJ. Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study. Value Health. 2011;14(1):34–40.CrossRefPubMedGoogle Scholar
  29. 29.
    Bachynsky J, Wiens C, Melnychuk K. The practice of splitting tablets: cost and therapeutic aspects. Pharmacoeconomics. 2002;20(5):339–46.CrossRefPubMedGoogle Scholar
  30. 30.
    Powell EC, Reynolds SL, Rubenstein JS. Theophylline toxicity in children: a retrospective review. Pediatr Emerg Care. 1993;9(3):129–33.CrossRefPubMedGoogle Scholar
  31. 31.
    Hocaoğlu N, Yıldıztepe E, Bayram B, Aydın B, Tunçok Y, Kalkan Ş. Demographic and clinical characteristics of theophylline exposures between 1993 and 2011. Balkan Med J. 2014;31(4):322–7.PubMedCentralCrossRefPubMedGoogle Scholar
  32. 32.
    Shannon M. Life-threatening events after theophylline overdose: a 10-year prospective analysis. Arch Intern Med. 1999;159:989–94.CrossRefPubMedGoogle Scholar
  33. 33.
    Hsu CC, Chou CY, Chou CL, Ho CC, Chen TJ, Chiang SC, et al. Impact of a warning CPOE system on the inappropriate pill splitting of prescribed medications in outpatients. PLoS ONE. 2014;9(12):e114359. doi: 10.1371/journal.pone.0114359 (eCollection 2014).PubMedCentralCrossRefPubMedGoogle Scholar
  34. 34.
    Wang BR, Chou CL, Hsu CC, Chou YC, Chen TJ, Chou LF. Drugs cheaper than threepenny: the market of extremely low-priced drugs within the National Health Insurance in Taiwan. ScientificWorldJournal. 2014;2014:234941. doi: 10.1155/2014/234941 (eCollection 2014).PubMedCentralPubMedGoogle Scholar
  35. 35.
    Elliott I, Mayxay M, Yeuichaixong S, Lee SJ, Newton PN. The practice and clinical implications of tablet splitting in international health. Trop Med Int Health. 2014;19(7):754–60.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2015

Authors and Affiliations

  • Chia-Lin Chou
    • 1
  • Chia-Chen Hsu
    • 1
  • Chia-Yu Chou
    • 2
    • 3
  • Tzeng-Ji Chen
    • 4
    • 5
  • Li-Fang Chou
    • 6
  • Yueh-Ching Chou
    • 1
    • 7
    • 8
    Email author
  1. 1.Department of PharmacyTaipei Veterans General HospitalTaipeiTaiwan, ROC
  2. 2.Department of Critical Care MedicineTaipei Veterans General HospitalTaipeiTaiwan, ROC
  3. 3.Department of MedicineTzu Chi UniversityHualianTaiwan, ROC
  4. 4.Institute of Hospital and Health Care Administration, School of MedicineNational Yang-Ming UniversityTaipeiTaiwan, ROC
  5. 5.Department of Family MedicineTaipei Veterans General HospitalTaipeiTaiwan, ROC
  6. 6.Department of Public FinanceNational Chengchi UniversityTaipeiTaiwan, ROC
  7. 7.Department and Institute of PharmacologyNational Yang-Ming UniversityTaipeiTaiwan, ROC
  8. 8.School of PharmacyTaipei Medical UniversityTaipeiTaiwan, ROC

Personalised recommendations

Cite article

Buy options